Back to News
Market Impact: 0.15
Galmed Pharma Rebrands To EoCene, Debuts EOCN Ticker As GI Expansion Accelerates; Stock Up
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Clinical-stage biopharmaceutical company Galmed Pharmaceuticals announced a corporate rebrand to Eocene Ltd. and will change its Nasdaq trading symbol from GLMD to EOCN. The announcement provides no financial results, clinical-data update, or change in operating guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
GLMD0.20
More News
- Pharvaris at Wells Fargo conference: oral HAE drug gains ground
- Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript
- Chewy (CHWY) Q2 2026 Earnings Call Transcript
- Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights
- Trump's oil investments have gained millions during Iran war as his accounts keep trading
- Chief Future Officer: Mandy Fields, e.l.f. Beauty